Press Room

Monday, March 8, 2010

Applied Spine Technologies to Present at the Canaccord Adams Musculoskeletal Conference

Applied Spine Technologies, Inc. www.appliedspine.com, a medical device company focused on motion preservation of the lumbar spine, today announced that Craig Corrance, President and Chief Executive Officer, will be presenting at the annual Canaccord Adams Musculoskeletal Conference. The event will be held in New Orleans at the Sheraton New Orleans Hotel.

Mr. Corrance’s presentation scheduled for Tuesday, March 9, 2010 at 9:20 AM (CST), will include an overview of the Company with an emphasis on the Stabilimax® Dynamic Spine Stabilization System IDE Clinical Trial, and the resulting strategic direction.

About Applied Spine Technologies Inc., and Stabilimax®

Applied Spine Technologies Inc., headquartered in Rocky Hill, Connecticut, is developing the Stabilimax Dynamic Spine Stabilization System, a posterior dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion. Stabilimax is expected to offer numerous advantages over current spinal fixation products and even new artificial disc products—including a much less invasive and less traumatic implant procedure, maintenance of spine motion and disc function, and the potential to prevent or slow adjacent-segment disc disease.

About the IDE Clinical Trial

Applied Spine Technologies, Inc. is currently conducting a multi-center, randomized, controlled clinical trial in the U.S. to compare posterior dynamic stabilization using the Stabilimax Dynamic Spine Stabilization System to traditional spinal fusion stabilization to treat degenerative lumbar spinal stenosis. AST has enrolled more than 100 patients to date.

Stabilimax is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.

---